Are biomarkers successfully used in from the Far East necessarily useful for an American population?

Studies by Rafael Molina, Chair of the European Group on Tumor Markers, show little to no variability between European and Chinese populations for most of the biomarkers in OneTest™. See e.g. Molina etc. Tumor Biology, April 2018: 1–13.